Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Current Pharmaceutical Design|July 2, 2011
Mitochondrial drug targets in cell death and cancerGustavo Ferrín, Clara I Linares, Jordi MuntanéJournal of Hepatocellular Carcinoma|January 8, 2019
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteriaVíctor Amado, Manuel Rodríguez-Perálvarez, Gustavo Ferrín, et al.International Journal of Molecular Sciences|February 20, 2020
Activation of mTOR Signaling Pathway in Hepatocellular CarcinomaGustavo Ferrín, Marta Guerrero, Víctor Amado, et al.Hepatic Medicine : Evidence and Research|May 1, 2015
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utilityGustavo Ferrín, Patricia Aguilar-Melero, Manuel Rodríguez-Perálvarez, et al.Mitochondrion|December 26, 2009
Isolation of mitochondria for biogenetical studies: An updateErika Fernández-Vizarra, Gustavo Ferrín, Acisclo Pérez-Martos, et al.Plos One|August 5, 2016
AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 ExpressionSandra González-Rubio, Clara I Linares, Patricia Aguilar-Melero, et al.The Journal of Surgical Research|August 3, 2014
Cardiotrophin-1 decreases liver apoptosis through calpastatin inductionCarmen Herencia, Yolanda Almadén, Gustavo Ferrín, et al.Plos Genetics|May 3, 2011
Evolution meets disease: penetrance and functional epistasis of mitochondrial tRNA mutationsRaquel Moreno-Loshuertos, Gustavo Ferrín, Rebeca Acín-Pérez, et al.The Journal of Surgical Research|February 21, 2012
Impact of age on liver regeneration response to injury after partial hepatectomy in a rat modelJuan Manuel Sánchez-Hidalgo, Alvaro Naranjo, Rubén Ciria, et al.International Journal of Molecular Sciences|December 10, 2021
Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical AppraisalMaría Lola Espejo-Cruz, Sandra González-Rubio, Javier Zamora-Olaya, et al.Pageof 4